174 related articles for article (PubMed ID: 31488436)
21. Liposomal delivery enhances short-chain ceramide-induced apoptosis of breast cancer cells.
Stover T; Kester M
J Pharmacol Exp Ther; 2003 Nov; 307(2):468-75. PubMed ID: 12975495
[TBL] [Abstract][Full Text] [Related]
22. Liposomes for drug delivery to mitochondria.
Boddapati SV; D'Souza GG; Weissig V
Methods Mol Biol; 2010; 605():295-303. PubMed ID: 20072889
[TBL] [Abstract][Full Text] [Related]
23. Lecithin-Based Dermal Drug Delivery for Anti-Pigmentation Maize Ceramide.
Kagotani K; Nakayama H; Zang L; Fujimoto Y; Hayashi A; Sono R; Nishimura N; Shimada Y
Molecules; 2020 Mar; 25(7):. PubMed ID: 32244349
[TBL] [Abstract][Full Text] [Related]
24. Synthetic, non-natural sphingolipid analogs inhibit the biosynthesis of cellular sphingolipids, elevate ceramide and induce apoptotic cell death.
Dagan A; Wang C; Fibach E; Gatt S
Biochim Biophys Acta; 2003 Sep; 1633(3):161-9. PubMed ID: 14499735
[TBL] [Abstract][Full Text] [Related]
25. In-vitro cytotoxic/cytostatic activity of anionic liposomes containing vinblastine against leukaemic human cell lines.
Maswadeh H; Demetzos C; Dimas K; Loukas YL; Georgopoulos A; Mavromoustakos T; Papaioannou GT
J Pharm Pharmacol; 2002 Feb; 54(2):189-96. PubMed ID: 11848282
[TBL] [Abstract][Full Text] [Related]
26. Pharmacology, clinical efficacy and adverse effects of vindesine sulfate, a new vinca alkaloid.
Cersosimo RJ; Bromer R; Licciardello JT; Hong WK
Pharmacotherapy; 1983; 3(5):259-74. PubMed ID: 6359081
[TBL] [Abstract][Full Text] [Related]
27. Immunoliposomes in Acute Myeloid Leukaemia Therapy: An Overview of Possible Targets and Obstacles.
Singh A; Myklebust NN; Furevik SMV; Haugse R; Herfindal L
Curr Med Chem; 2019; 26(28):5278-5292. PubMed ID: 31099318
[TBL] [Abstract][Full Text] [Related]
28. Interdiction of Sphingolipid Metabolism Revisited: Focus on Prostate Cancer.
Voelkel-Johnson C; Norris JS; White-Gilbertson S
Adv Cancer Res; 2018; 140():265-293. PubMed ID: 30060812
[TBL] [Abstract][Full Text] [Related]
29. Novel therapeutic nano-particles (lipocores): trapping poorly water soluble compounds.
Perkins WR; Ahmad I; Li X; Hirsh DJ; Masters GR; Fecko CJ; Lee J; Ali S; Nguyen J; Schupsky J; Herbert C; Janoff AS; Mayhew E
Int J Pharm; 2000 Apr; 200(1):27-39. PubMed ID: 10845683
[TBL] [Abstract][Full Text] [Related]
30. Systemic delivery of liposomal short-chain ceramide limits solid tumor growth in murine models of breast adenocarcinoma.
Stover TC; Sharma A; Robertson GP; Kester M
Clin Cancer Res; 2005 May; 11(9):3465-74. PubMed ID: 15867249
[TBL] [Abstract][Full Text] [Related]
31. New therapeutic approach for myeloid leukemia: induction of apoptosis via modulation of reactive oxygen species production by natural compounds.
Kizaki M
Int J Hematol; 2006 May; 83(4):283-8. PubMed ID: 16757425
[TBL] [Abstract][Full Text] [Related]
32. Systemic Codelivery of a Homoserine Derived Ceramide Analogue and Curcumin to Tumor Vasculature Inhibits Mouse Tumor Growth.
Barui S; Saha S; Yakati V; Chaudhuri A
Mol Pharm; 2016 Feb; 13(2):404-19. PubMed ID: 26716471
[TBL] [Abstract][Full Text] [Related]
33. Novel mechanisms of action of classical chemotherapeutic agents on sphingolipid pathways.
Hajj C; Becker-Flegler KA; Haimovitz-Friedman A
Biol Chem; 2015 Jun; 396(6-7):669-79. PubMed ID: 25719313
[TBL] [Abstract][Full Text] [Related]
34. Introduction: Enigmas of Sphingolipids.
Stiban J
Adv Exp Med Biol; 2019; 1159():1-3. PubMed ID: 31502196
[TBL] [Abstract][Full Text] [Related]
35. Paclitaxel-induced apoptosis in Jurkat, a leukemic T cell line, is enhanced by ceramide.
Myrick D; Blackinton D; Klostergaard J; Kouttab N; Maizel A; Wanebo H; Mehta S
Leuk Res; 1999 Jun; 23(6):569-78. PubMed ID: 10374850
[TBL] [Abstract][Full Text] [Related]
36. Development and use of ceramide nanoliposomes in cancer.
Watters RJ; Kester M; Tran MA; Loughran TP; Liu X
Methods Enzymol; 2012; 508():89-108. PubMed ID: 22449922
[TBL] [Abstract][Full Text] [Related]
37. Novel ophthalmic formulation of myriocin: implications in retinitis pigmentosa.
Platania CBM; Dei Cas M; Cianciolo S; Fidilio A; Lazzara F; Paroni R; Pignatello R; Strettoi E; Ghidoni R; Drago F; Bucolo C
Drug Deliv; 2019 Dec; 26(1):237-243. PubMed ID: 30883241
[TBL] [Abstract][Full Text] [Related]
38. Anti-Cancerous Potential of Polyphenol-Loaded Polymeric Nanotherapeutics.
Ernest U; Chen HY; Xu MJ; Taghipour YD; Asad MHHB; Rahimi R; Murtaza G
Molecules; 2018 Oct; 23(11):. PubMed ID: 30373235
[TBL] [Abstract][Full Text] [Related]
39. Measurement of ceramide and sphingolipid metabolism in tumors: potential modulation of chemotherapy.
Modrak DE
Methods Mol Med; 2005; 111():183-94. PubMed ID: 15911980
[TBL] [Abstract][Full Text] [Related]
40. Ceramide synthases as potential targets for therapeutic intervention in human diseases.
Park JW; Park WJ; Futerman AH
Biochim Biophys Acta; 2014 May; 1841(5):671-81. PubMed ID: 24021978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
